X0202 3 2007-02-01 0 0001340752 Molecular Insight Pharmaceuticals, Inc. MIPI 0001388056 McCray John E MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Operating Officer Common 178638 D Common 16666 I by Trust Employee Stock Option 1.20 2015-02-18 Common Stock 40833 D Employee Stock Option 4.80 2015-05-09 Common Stock 58333 D Employee Stock Option 0.60 2015-02-17 Common Stock 21048 D Held through the John E. McCray Grantor Retained Annuity Trust 2007, over which the reporting person has investment control. 50% of the underlying shares vest in equal annual installments over a four-year period beginning on February 18, 2006. The balance of the underlying shares vests on February 18, 2009, subject to acceleration upon reaching certain milestone performance objectives. Prior to the reporting date, the reporting person has exercised this option with respect to certain underlying shares. This option vests in four equal annual installments beginning on May 9, 2006. 20% of the underlying shares vested upon the date of grant. An additional 5% of the underlying shares vest quarterly over a four-year period commencing on July 8, 2003. Prior to the reporting date, the reporting person has exercised this option with respect to certain underlying shares. Adria E. Warren, Esq., as Attorney-in-Fact for John E. McCray 2007-02-01